Home » Healthcare » Cosmetic Surgery And Procedure Market
Cosmetic Surgery And Procedure Market By Procedure (Surgical Procedures, Non-Surgical Procedures); By Gender (Female, Male); By Age Group (18 Years, Younger); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Cosmetic Surgery And Procedure Market size was valued USD 83070 million in 2024 and is anticipated to reach USD 179236.8 million by 2032, at a CAGR of 10.09% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Cosmetic Surgery And Procedure Market Size 2024
USD 83070 million
Cosmetic Surgery And Procedure Market, CAGR
10.09%
Cosmetic Surgery And Procedure Market Size 2032
USD 179236.8 million
Cosmetic Surgery And Procedure Market Insights
Key market drivers include increasing demand for non-surgical procedures, shorter recovery times, technological advancements in energy-based devices, and growing acceptance of cosmetic treatments across male and aging populations.
Major market trends highlight rapid growth in non-surgical procedures, which account for over 55% segment share, along with increasing use of combination therapies and AI-enabled treatment planning for personalized outcomes.
The competitive landscape is characterized by established global players focusing on innovation, regulatory compliance, clinician training, and strategic partnerships to strengthen product portfolios and expand outpatient procedure coverage.
Regionally, North America leads with an exact 38% market share, followed by Europe at around 30% and Asia-Pacific at approximately 22%, with Asia-Pacific showing the fastest growth due to rising medical tourism and disposable income.
Cosmetic Surgery And Procedure Market Segmentation Analysis:
By Procedure
The cosmetic surgery and procedure market is segmented into surgical and non-surgical procedures, with non-surgical procedures emerging as the dominant sub-segment, accounting for approximately 58% of total market share. This dominance is driven by strong demand for minimally invasive treatments such as botulinum toxin injections, dermal fillers, chemical peels, and laser-based skin rejuvenation. Key drivers include shorter recovery times, lower procedural risks, reduced costs compared to surgery, and rising acceptance of aesthetic treatments for routine appearance enhancement. Continuous advancements in injectable formulations and energy-based devices further support repeat procedures and sustained volume growth.
For instance, Merit Medical Systems, Inc. supports non-surgical aesthetics through precision delivery solutions such as its Merit Aesthetics cannulas available in 22G to 25G gauges with working lengths ranging from 38 mm to 70 mm, and disposable syringes engineered for controlled delivery in 1 mL and 3 mL formats, enhancing injection accuracy and procedural consistency in filler and toxin treatments.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
By gender, the market is divided into female and male consumers, with females representing the dominant sub-segment at nearly 72% market share. Higher adoption among women is driven by greater aesthetic awareness, strong influence of social media and beauty standards, and wider acceptance of cosmetic enhancements across age groups. Demand is particularly strong for facial aesthetics, body contouring, and skin rejuvenation procedures. However, the male segment continues to expand steadily, supported by growing interest in non-surgical facial treatments, hair restoration, and body sculpting, reflecting evolving perceptions around male grooming and self-care.
For instance, Owens & Minor, Inc. enables consistent access to gender-diverse aesthetic procedures through its medical distribution infrastructure, operating more than 30 distribution centers with over 8 million square feet of warehouse space and managing an inventory exceeding 220,000 medical SKUs, while maintaining order-fill accuracy levels above 99.8% across physician offices, outpatient clinics, and surgical centers, directly supporting procedural reliability and clinical throughput.
By Age Group
Based on age group, the market includes 18 years and younger, 19–34 years, 35–50 years, 51–64 years, and 65 years & above, with the 35–50 years segment leading at approximately 34% market share. This group demonstrates high demand for both preventive and corrective procedures, including injectables, skin tightening, and minimally invasive contouring. Key drivers include higher disposable income, early intervention to address aging signs, and preference for combination treatments that deliver natural-looking outcomes. Growing aesthetic awareness among younger adults and rising longevity trends also support demand across adjacent age segments.
Key Growth Drivers
Rising Demand for Minimally Invasive Procedures
The cosmetic surgery and procedure market continues to expand as patients increasingly prefer minimally invasive and non-surgical treatments that offer reduced recovery time, lower procedural risk, and natural-looking outcomes. Advances in injectables, laser-based therapies, and energy-based devices enable practitioners to deliver effective aesthetic enhancements with minimal downtime. Growing acceptance of preventive and maintenance-oriented aesthetic treatments among younger demographics further strengthens demand. Additionally, continuous improvements in safety profiles, precision, and customization have increased patient confidence, supporting higher procedure volumes across both surgical and non-surgical segments globally.
For instance, AngioSystems Inc. supports procedural safety and workflow efficiency in interventional environments with its SorbX scatter radiation protection shields, having produced over 1,000,000 shields for clinical use since launch, and maintains ISO 13485 certification for quality management across device manufacturing.
Technological Advancements in Aesthetic Devices and Techniques
Rapid innovation in aesthetic technologies acts as a critical growth driver by enhancing clinical outcomes and expanding treatment applications. High-definition imaging, AI-assisted treatment planning, and next-generation laser and radiofrequency systems improve procedural accuracy and consistency. These advancements enable practitioners to offer personalized treatment protocols tailored to individual anatomy and skin type. Continuous upgrades in implants, fillers, and regenerative techniques also contribute to longer-lasting results and improved safety, reinforcing patient trust and driving repeat procedures in mature and emerging markets.
For instance, Cardinal Health, Inc. advances clinical operations and supply chain reliability through measurable technology and infrastructure investments its U.S. medical products distribution network comprises at least 40 warehouses, each participating in innovation initiatives such as a 4,000 square-foot Innovation Lab dedicated to testing autonomous mobile robots (AMRs), collaborative devices, and next-generation scanning tools to improve pick-pack efficiency and occupational safety.
Growing Aesthetic Awareness and Expanding Consumer Base
Increasing aesthetic awareness driven by social media, digital influence, and changing beauty standards significantly fuels market growth. Greater visibility of cosmetic procedures has normalized aesthetic enhancement across genders and age groups, expanding the addressable patient pool. Rising disposable incomes, especially in emerging economies, support higher spending on elective cosmetic procedures. Moreover, increasing workplace competitiveness and emphasis on personal appearance encourage individuals to seek aesthetic treatments, strengthening sustained demand across facial, body contouring, and skin rejuvenation procedures.
Key Trends & Opportunities
Shift Toward Combination and Customized Treatments
A key trend shaping the market is the growing adoption of combination therapies that integrate surgical and non-surgical procedures to achieve comprehensive aesthetic outcomes. Practitioners increasingly combine injectables, energy-based devices, and surgical interventions to enhance results and reduce the need for repeat surgeries. Customization based on patient-specific goals and anatomical considerations improves satisfaction rates and clinical outcomes. This trend creates opportunities for clinics to differentiate services, increase per-patient revenue, and strengthen long-term patient relationships.
For instance, 3M Company has advanced material science and precision-manufacturing technologies that support clinical and procedural environments, including its 3M™ Sun Control Window Film Prestige Series engineered with multilayer optical film structures consisting of more than 200 alternating layers to manage solar heat without metal, and 3M™ Filtek™ Universal Restorative dental composite formulated with nanofiller particles such as 20-nanometer silica and 4-micron zirconia clusters for improved strength and wear resistance in restorative procedures.
Expansion of Male and Geriatric Aesthetic Procedures
The market is witnessing rising participation from male and older patient segments, creating new growth opportunities. Men increasingly seek procedures related to facial rejuvenation, body contouring, and hair restoration, driven by professional and social motivations. Simultaneously, the aging population drives demand for age-defying treatments that maintain a natural appearance rather than dramatic alteration. This demographic diversification encourages the development of targeted procedures, marketing strategies, and treatment protocols tailored to distinct patient profiles.
For instance, Medline Industries, LP has advanced its clinical supply and product innovation capabilities through measurable technology deployments it operates 20 active AutoStore robotic storage and retrieval installations staffed by over 1,800 autonomous robots across U.S.
Growth of Medical Tourism and Emerging Markets
Medical tourism presents a significant opportunity as patients seek cost-effective cosmetic procedures without compromising quality. Countries with advanced healthcare infrastructure, skilled surgeons, and competitive pricing attract international patients for both surgical and non-surgical treatments. Emerging markets also benefit from increasing investments in aesthetic clinics, rising practitioner training standards, and expanding urban middle-class populations. These factors collectively support geographic market expansion and cross-border patient inflows.
Key Challenges
High Procedure Costs and Limited Reimbursement
Despite growing demand, high costs associated with cosmetic surgery and advanced aesthetic procedures remain a major challenge. Most procedures are elective and not covered by insurance, limiting accessibility for price-sensitive consumers. Capital-intensive investments in advanced devices and skilled personnel increase operational costs for clinics, which are often passed on to patients. This pricing barrier can restrict market penetration, particularly in developing regions, and slow adoption of premium or technologically advanced treatments.
Regulatory and Safety Concerns
Stringent regulatory requirements and ongoing safety concerns pose challenges to market growth. Regulatory bodies impose strict approval processes for devices, implants, and injectable products, extending time-to-market for new innovations. Additionally, rising scrutiny around practitioner qualifications and adverse event reporting increases compliance costs for clinics. Any high-profile procedural complications can negatively impact patient perception and trust, emphasizing the need for rigorous training, standardized protocols, and continuous monitoring across the cosmetic surgery and procedure market.
Regional Analysis
North America
North America dominates the Cosmetic Surgery and Procedure Market, accounting for 38% market share, driven by high disposable income, strong aesthetic awareness, and widespread acceptance of cosmetic enhancements. The region benefits from advanced healthcare infrastructure, a high concentration of board-certified plastic surgeons, and rapid adoption of minimally invasive procedures such as botulinum toxin injections, dermal fillers, and laser-based treatments. The U.S. leads regional demand due to frequent procedure volumes, strong medical tourism inflows, and continuous product innovation. Social media influence, celebrity culture, and growing male participation further sustain procedural demand across both surgical and non-surgical categories.
Europe
Europe represents approximately 30% market share, supported by strong demand across Western European countries such as Germany, France, Italy, and the U.K. The region benefits from well-established medical aesthetics clinics, strict regulatory standards ensuring patient safety, and rising acceptance of non-invasive cosmetic procedures. Minimally invasive treatments dominate growth due to shorter recovery times and lower costs. Eastern Europe is emerging as a medical tourism hub, attracting patients with cost-effective surgical procedures. Aging demographics, increasing demand for facial rejuvenation, and advancements in laser and energy-based devices continue to reinforce Europe’s stable market expansion.
Asia-Pacific
Asia-Pacific holds around 22% market share and is the fastest-growing regional market, driven by expanding middle-class populations, rising disposable incomes, and strong cultural emphasis on aesthetic appearance. Countries such as South Korea, China, Japan, and India lead demand, particularly for facial surgeries, skin resurfacing, and body contouring procedures. South Korea remains a global center for cosmetic surgery expertise, while China and India benefit from large patient pools and improving healthcare access. Increasing medical tourism, social media influence, and rapid adoption of non-surgical procedures significantly accelerate regional market penetration.
Latin America
Latin America accounts for approximately 7% market share, supported by strong demand in Brazil, Mexico, and Colombia. Brazil is a global leader in cosmetic surgical volumes, driven by cultural acceptance of aesthetic procedures and a high number of skilled plastic surgeons. Cost-effective treatment options attract both domestic and international patients, particularly for body contouring and facial surgeries. Non-surgical procedures are also gaining momentum due to affordability and minimal downtime. Growing urbanization, increasing aesthetic awareness, and expanding private healthcare facilities continue to support steady regional growth.
Middle East & Africa
The Middle East & Africa region holds about 3% market share, with growth concentrated in Gulf Cooperation Council countries such as the UAE and Saudi Arabia. Rising disposable incomes, expanding medical tourism, and increasing demand for premium aesthetic services support regional development. Non-invasive cosmetic procedures dominate due to cultural preferences and reduced recovery periods. The UAE, particularly Dubai, serves as a regional hub for advanced cosmetic clinics. In Africa, market growth remains moderate but improving healthcare infrastructure and rising awareness of aesthetic treatments are gradually expanding the patient base.
Cosmetic Surgery And Procedure Market Segmentations:
By Procedure:
Surgical Procedures
Non-Surgical Procedures
By Gender:
Female
Male
By Age Group:
18 Years
Younger
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The competitive landscape of the Cosmetic Surgery and Procedure Market players such as Merit Medical Systems, Inc.; Becton, Dickinson and Company; Owens & Minor, Inc.; AngioSystems Inc.; Mölnlycke Health Care AB; Cardinal Health, Inc.; 3M Company; Medline Industries, LP; Baxter International Inc.; B. Braun Melsungen AG. the Cosmetic Surgery and Procedure Market is defined by intense competition focused on innovation, procedural safety, and service reliability. Market participants prioritize the development of minimally invasive technologies, advanced consumables, and infection-control solutions to meet the growing demand for outpatient and office-based aesthetic procedures. Strong emphasis is placed on regulatory compliance, clinical validation, and consistent product quality to build long-term trust with surgeons and aesthetic practitioners. Companies also strengthen their positions through efficient global distribution networks, training programs for clinicians, and portfolio expansion aligned with evolving treatment preferences. Continuous investment in research, digital workflow integration, and supply-chain resilience further enhances competitiveness, enabling providers to support high procedure volumes while maintaining patient safety and operational efficiency.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In June 2025, Aestiva Plastic Surgery, an aesthetic and reconstructive clinic based in Saket, Delhi, has unveiled a revolutionary Scarless Facial Contouring technique, a first-of-its-kind solution for individuals seeking facial sculpting without visible marks.
In February 2025, The U.S. Food and Drug Administration (FDA) approved the Evolysse hyaluronic acid fillers, Evolysse Form and Evolysse Smooth. Both products are indicated for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLFs).
In December 2024, Lorena Cosmetics has re-launched the sk:n and The Harley Medical Group (THMG) aesthetic and cosmetic surgery clinic chains. Lorena Investments acquires skin clinics and The Harley Medical Group, intensifying U.K. clinic consolidation.
Report Coverage
The research report offers an in-depth analysis based on Procedure,Gender, Age Group and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Minimally invasive and non-surgical procedures will continue to gain preference due to reduced downtime, lower risk, and faster patient recovery.
Advancements in laser, radiofrequency, and ultrasound-based technologies will improve precision, safety, and treatment outcomes.
Growing acceptance of cosmetic procedures among male and aging populations will expand the overall patient base.
Integration of artificial intelligence and digital imaging will enhance treatment planning, customization, and outcome predictability.
Demand for combination therapies that deliver natural-looking and long-lasting results will increase across facial and body procedures.
Medical tourism will strengthen cross-border procedure volumes, particularly in cost-competitive and high-expertise regions.
Clinics will increasingly adopt outpatient and office-based procedural models to improve efficiency and patient convenience.
Regulatory emphasis on product safety and practitioner certification will raise quality standards across the market.
Personalized aesthetic treatments tailored to individual anatomy and skin characteristics will gain wider adoption.
Ongoing innovation in injectables, energy-based devices, and biomaterials will sustain long-term market growth.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Cosmetic Surgery and Procedure Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Procedure
6.1. Surgical Procedures
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Non-Surgical Procedures
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity 7. Market Breakup by Gender
7.1. Female
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Male
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity 8. Market Breakup by Age Group
8.1. 18 Years
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Younger
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity 9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast 10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats 11. Value Chain Analysis 12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Merit Medical Systems, Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Becton, Dickinson and Company
14.3.3. Owens & Minor, Inc.
14.3.4. AngioSystems Inc.
14.3.5. Mölnlycke Health Care AB
14.3.6. Cardinal Health, Inc.
14.3.7. 3M Company
14.3.8. Medline Industries, LP
14.3.9. Baxter International Inc.
14.3.10. B. Braun Melsungen AG 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for the Cosmetic Surgery And Procedure Market, and what is its projected size in 2032?
The market was valued at USD 83,070 million in 2024 and is projected to reach USD 179,236.8 million by 2032.
At what Compound Annual Growth Rate is the Cosmetic Surgery And Procedure Market projected to grow between 2024 and 2032?
The market is expected to grow at a CAGR of 10.09% during the forecast period.
Which Cosmetic Surgery And Procedure Market segment held the largest share in 2024?
Non-surgical procedures held the largest share, accounting for approximately 58% of the total market.
What are the primary factors fueling the growth of the Cosmetic Surgery And Procedure Market?
Key factors include rising demand for minimally invasive procedures, technological advancements, and growing aesthetic awareness across age groups and genders.
Who are the leading companies in the Cosmetic Surgery And Procedure Market?
The market is led by established global medical device and healthcare solution providers with strong portfolios in surgical, non-surgical, and procedural support products.
Which region commanded the largest share of the Cosmetic Surgery And Procedure Market in 2024?
North America led the market with an exact 38% share, supported by high procedure volumes and advanced healthcare infrastructure.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Dilated Cardiomyopathy Therapeutic Market size was estimated at USD 5,240.95 million in 2025 and is expected to reach USD 8,025.37 million by 2032, growing at a CAGR of 7.36% from 2025 to 2032.
The global Digital Pathology Image Analysis Market size was estimated at USD 3,425.85 million in 2025 and is expected to reach USD 7,503.83 million by 2032, growing at a CAGR of 13.96% from 2025 to 2032.
The Divalproex Sodium Market size was estimated at USD 1,860.58 million in 2025 and is expected to reach USD 2,453.73 million by 2032, growing at a CAGR of 4.72% from 2025 to 2032.
The global somatostatin analogs market was valued at USD 7,187.5 million in 2024 and is projected to reach USD 12,349.46 million by 2032, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period.
The global respiratory disease vaccine market was valued at USD 94,579.5 million in 2024 and is projected to reach USD 102,011.14 million by 2032, expanding at a compound annual growth rate (CAGR) of 2.1% during the forecast period
The hepatic encephalopathy market was valued at USD 1432.5 million in 2024 and is expected to reach USD 2176.7 million by 2032, registering a CAGR of 5.4% during the forecast period.
The cardiac pacemakers market was valued at USD 5,298 million in 2024 and is expected to reach USD 7,702.9 million by 2032. The market is projected to grow at a CAGR of 4.79% during the forecast period.
The cancer immunotherapy drug discovery outsourcing market was valued at USD 1,432 million in 2024 and is expected to reach USD 2,981.48 million by 2032. The market is projected to grow at a CAGR of 9.6% during the forecast period.
The global healthcare cloud infrastructure market was valued at USD 76,788 million in 2024 and is projected to reach USD 260,555.1 million by 2032, expanding at a compound annual growth rate (CAGR) of 16.5% during the forecast period
The pregabalin market reached USD 1,794.5 million in 2024 and is projected to reach USD 2,631.16 million by 2032, growing at a CAGR of 4.9% during the forecast period. (Credence Research Data)
The Pregnancy Medication market was valued at USD 42,234.5 million in 2024 and is expected to reach USD 124,770.3 million by 2032, expanding at a CAGR of 14.5% during the forecast period.
The Germany guidewires market was valued at USD 151 million in 2024 and is projected to reach USD 229.68 million by 2032, registering a CAGR of 5.4% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
